BiomX Inc. COmmon Stock (PHGE)
6.5800
-0.3700 (-5.32%)
NYSE · Last Trade: Jan 28th, 6:26 PM EST
Let's take a look at the stocks that are in motion in today's session.chartmill.com
Via Chartmill · January 27, 2026
In today's session, these stocks are experiencing unusual volume.chartmill.com
Via Chartmill · January 27, 2026
Let's have a look at the top gainers and losers in the middle of the day of today's session.chartmill.com
Via Chartmill · January 27, 2026
The market is filled with gapping stocks in Tuesday's session.chartmill.com
Via Chartmill · January 27, 2026
Wondering what's happening in today's pre-market session?chartmill.com
Via Chartmill · January 27, 2026
Wondering what's happening in today's after-hours session?chartmill.com
Via Chartmill · January 26, 2026
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · December 29, 2025
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · December 8, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.
Via Chartmill · December 8, 2025
Wondering what's happening in Monday's pre-market session? Find an overview in this article.
Via Chartmill · December 8, 2025
Via Benzinga · November 17, 2025
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via Chartmill · November 14, 2025
Via Benzinga · November 10, 2025
Via Benzinga · October 31, 2025
Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session. The market value of their outstanding shares is at $87.2 million.
Via Benzinga · September 25, 2025
Via Benzinga · August 19, 2025
Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics.
Via Chartmill · August 19, 2025
BiomX Inc (PHGE) reports Q2 2025 earnings surprise with EPS of $0.19 vs. expected loss, sparking a 142% pre-market surge. Phase 2 results for BX211 show promising efficacy in diabetic foot osteomyelitis treatment.
Via Chartmill · August 13, 2025
Discover the stocks with unexpected trading volume in today's session on the US markets.
Via Chartmill · August 7, 2025
Via Benzinga · August 6, 2025